Expand CTXR Menu
CTXR MENU

CTXR Stock Posts


Unusual Option Volume

CTXR Citius Pharmaceuticals1.51+0.29 (+23.8%)

Citius Pharmaceuticals trades 2,585 contracts.
View Details...
Unusual Option Volume

CTXR Citius Pharmaceuticals1.80+0.35 (+24.1%)

Citius Pharmaceuticals trades 2,336 contracts. The company has the following event: LD Micro Main Event XIX between Oct 19, 2025 and Oct 21, 2025. News: Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR Commercial Launch
View Details...
Unusual Option Volume

CTXR Citius Pharmaceuticals1.53+0.14 (+10.1%)

Citius Pharmaceuticals trades 2,493 contracts. News: Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR
View Details...
Unusual Option Volume

CTXR Citius Pharmaceuticals1.71+0.38 (+28.6%)

Citius Pharmaceuticals trades 2,409 contracts.
View Details...
Unusual Option Volume

CTXR Citius Pharmaceuticals1.95+1.10 (+129.1%)

Citius Pharmaceuticals trades 4,366 contracts. News: Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
View Details...
Unusual Option Volume

CTXR Citius Pharmaceuticals0.88-0.03 (-2.9%)

Citius Pharmaceuticals trades 3,281 contracts. The company has the following event: on Aug 8, 2024. News: Citius Pharmaceuticals Receives FDA Approval for LYMPHIR (denileukin diftitox-cxdl) Immunotherapy for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes